Strain Name: |
FVB.129(B6)-Smn1tm1Jme/J |
|---|---|
Stock Number: |
006138 |
Availability: | Repository- Live |
General Terms and Conditions |
| Former Name |
FVB.Cg-Smn1tm1Jme/J (Changed: 15-MAR-07
) |
| Genes & Alleles | Smn1; Smn1tm1Jme; |
Type JAX® GEMM® Strain - Congenic Additional information on JAX® GEMM® Strains. Type JAX® GEMM® Strain - Mutant Strain Type JAX® GEMM® Strain - Targeted Mutation Mating System Homozygote x Homozygote (Female x Male) Species laboratory mouse Donating Investigator IMR Colony, The Jackson Laboratory Generation ?+N5F3 (01-MAY-08) Strain Description
Mice homozygous for this SMNF7 floxed allele are viable and fertile and do not display any gross physical or behavioral abnormalities. Mutant mice exhibit no transcript splicing defects. Cre-mediated recombination of the loxP-flanked sequences results in deletion of exon 7 of the targeted gene. As mutations of this exon are implicated in 95% of all human spinal muscular atrophy (SMA), these mice may be useful in studying SMA or other neuromuscular degenerative diseases.When crossed to a strain expressing Cre recombinase in neurons (ssee Stock No. 005938, Stock No. 006297, and Stock No. 006663), this mutant mouse strain may be useful as a model of SMA.
When crossed to a strain expressing Cre recombinase in striated muscle fibers (see Stock No. 005936, Stock No. 006139, and Stock No. 006149), this mutant mouse strain may be useful as a model of SMA.
SMNF7 mice are available on different genetic backgrounds (see Stock No. 006138 and Stock No. 006146). In an attempt to offer alleles on well-characterized or multiple genetic backgrounds, alleles are frequently moved to a genetic background different from that on which an allele was first characterized. It should be noted that the SMNF7 phenotype could vary from that originally described on a mixed genetic background. We will modify the strain description if necessary as published results become available.
Importation of this model was supported by the Spinal Muscular Atrophy Foundation. Creation and development was supported by the National Institute of Health and Medical Research of France (Inserm) and the Association Française contre les Myopathies (AFM). An additional help was provided by Families of SMA (U.S.A.) and Andrew’s Buddies (U.S.A.).
Strain Development
A targeting vector was used to insert a neomycin resistance gene within intron 6 and place loxP sites immediately flanking exon 7 of the endogenous gene. This construct was electroporated into “129Sv” embryonic stem (ES) cells. Correctly targeted cells were injected into blastocysts. The resulting chimeric males were bred to C57BL/6J females. Heterozygous offspring were bred to generate homozygous mice. Homozygotes on this mixed B6;129 background were bred together for approximately 5 years before arrival at The Jackson Laboratory. After arriving, mutant mice were backcrossed to FVB/NJ (Stock No. 001800) for 5-10 generations.
Related Disease (OMIM) Terms |
Mammalian Phenotype Terms assigned by genotype |
| Allele Symbol | Smn1tm1Jme | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Judith Melki | ||
| Common Name(s) | SMNF7; | ||
| Mutation Made By | Judith Melki, Genopole, Inserm U798 | ||
| Strain of Origin | 129 | ||
| ES Cell Line Strain | 129 | ||
| Gene Symbol and Name | Smn1, survival motor neuron 1 | ||
| Chromosome | 13 | ||
| Gene Common Name(s) | AI849087; BCD541; SMA; SMA1; SMA2; SMA3; SMA4; SMA@; SMN; SMNT; Smn; T-BCD541; expressed sequence AI849087; survival motor neuron; | ||
| Molecular Note | A floxed exon 7 and neomycin resistance cassette were introduced to the gene via homologous recombination. The floxed exon 7 and neo cassette do not appear to interfere with transcript splicing in mutant animals as determined by RT-PCR analysis. [MGI Ref ID J:61396] | ||
| Control | ||
|---|---|---|
| 001800 FVB/NJ | ||
| Considerations for Choosing Controls | ||
Smn1tm1Jme
| Breeding & Husbandry | When maintaining a live colony, homozygous mice may be bred. |
|---|---|
| Diet Information | LabDiet® 5K52/5K67 |
Strains carrying Smn1tm1Jme allele
006146 B6.129-Smn1tm1Jme/J View Strains carrying Smn1tm1Jme (1 strain)
Strains carrying other alleles of Smn1
View Strains carrying other alleles of Smn1 (15 strains)
Congenic Nomenclature
Cre-lox or FLP-FRT Systems
Room Number AX11
Neurobiology Research
Cre-lox System (loxP-flanked Sequences)
Neurodegeneration
Neuromuscular Defects
Spinal Muscular Atrophy (SMA)
Research Tools
Cre-lox System (loxP-flanked Sequences)
Neurobiology Research
Selected Reference(s)
Additional ReferencesFrugier T; Tiziano FD; Cifuentes-Diaz C; Miniou P; Roblot N; Dierich A; Le Meur M; Melki J. 2000. Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy. Hum Mol Genet 9(5):849-58. [PubMed: 10749994] [MGI Ref ID J:61396]
| Strain Name: | FVB.129(B6)-Smn1tm1Jme/J |
| Stock Number: | 006138 |
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of ~nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within 48 hours of order placement. |
|---|---|
| Supply Notes |
Usually shipped between four and eight weeks of age. This strain is included in the Induced Mutant Resource Colony collection. |
| Licensing | See General Terms and Conditions below for Licensing and Use Restrictions |
| Control Information | View Control Information in Strain Details. |
Effective September 26, 2007: License Requirements for Strains using Cre-lox Technology only apply in Canada, see Licenses for Strains using Cre-lox Technology.
For additional Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form